Royce & Associates LP Buys New Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Royce & Associates LP bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 11,595 shares of the medical instruments supplier’s stock, valued at approximately $220,000.

Several other hedge funds have also made changes to their positions in XRAY. Pacer Advisors Inc. lifted its stake in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after buying an additional 4,473,972 shares during the period. Cooke & Bieler LP lifted its stake in DENTSPLY SIRONA by 24.3% during the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after purchasing an additional 1,794,391 shares during the period. JPMorgan Chase & Co. lifted its stake in DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the period. Invenomic Capital Management LP bought a new position in DENTSPLY SIRONA during the third quarter worth about $23,724,000. Finally, National Bank of Canada FI lifted its stake in DENTSPLY SIRONA by 85.8% during the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock worth $44,059,000 after purchasing an additional 751,800 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

XRAY opened at $15.56 on Friday. The company has a fifty day moving average price of $17.92 and a two-hundred day moving average price of $20.53. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 52 week low of $14.78 and a 52 week high of $33.52. The firm has a market capitalization of $3.10 billion, a PE ratio of -7.52, a P/E/G ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.52% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Wells Fargo & Company dropped their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.